- Company Directors - H
- Hoffman Stephen J
Insider Trading History of Hoffman Stephen J
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Hoffman Stephen J since 2008.
The trader's CIK number is 1190418.
At the time of the last reporting, Hoffman Stephen J was the Director of Aerpio Pharmaceuticals, Inc.. (stock ticker symbol ARPO).
Also see all insider trading activities at Aerpio Pharmaceuticals, Inc..
Note that in the past
HOFFMAN STEPHEN J also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Dicerna Pharmaceuticals Inc (DRNA) by Hoffman Stephen J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | DRNA | 200,000 | $3,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Genocea Biosciences, Inc. (GNCA) by Hoffman Stephen J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | GNCA | 700,000 | $5,775,000 | 0 | $0 | 0 | $0 |
| 2014 | GNCA | 250,931 | $3,011,172 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Allos Therapeutics Inc (ALTH) by Hoffman Stephen J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | ALTH | 0 | $0 | 252,571 | $1,737,640 | 252,571 | $610,966 |
| 2009 | ALTH | 0 | $0 | 36,400 | $328,692 | 36,400 | $88,051 |
| 2008 | ALTH | 0 | $0 | 40,000 | $387,200 | 40,000 | $96,760 |
Yearly summary of insider trading at Aerpio Pharmaceuticals, Inc. (ARPO) by Hoffman Stephen J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | ARPO | 31,967 | $64,134 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Hoffman Stephen J:
1. Dicerna Pharmaceuticals Inc (DRNA)
2. Genocea Biosciences, Inc. (GNCA)
3. Allos Therapeutics Inc (ALTH)
4. Aerpio Pharmaceuticals, Inc. (ARPO)
Table 1. Insider trading of Dicerna Pharmaceuticals Inc (DRNA) by Hoffman Stephen J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-02-04 | DRNA | Buy | 200,000 | 15.00 | 3,000,000 |
Table 2. Insider trading of Genocea Biosciences, Inc. (GNCA) by Hoffman Stephen J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-03-17 | GNCA | Buy | 700,000 | 8.25 | 5,775,000 |
| 2014-02-10 | GNCA | Buy | 250,931 | 12.00 | 3,011,172 |
Table 3. Insider trading of Allos Therapeutics Inc (ALTH) by Hoffman Stephen J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-01-08 | ALTH | Sale | 45,429 | 7.11 | 322,909 |
| 2010-01-07 | ALTH | Sale | 45,429 | 6.76 | 307,100 |
| 2010-01-08 | ALTH | Option Ex | 45,429 | 2.42 | 109,892 |
| 2010-01-07 | ALTH | Option Ex | 45,429 | 2.42 | 109,892 |
| 2010-01-11 | ALTH | Option Ex | 45,428 | 2.42 | 109,890 |
| 2010-01-11 | ALTH | Sale | 45,428 | 7.30 | 331,760 |
| 2010-01-04 | ALTH | Option Ex | 25,428 | 2.42 | 61,510 |
| 2010-01-06 | ALTH | Sale | 45,429 | 6.78 | 308,144 |
| 2010-01-05 | ALTH | Sale | 45,428 | 6.64 | 301,505 |
| 2010-01-06 | ALTH | Option Ex | 45,429 | 2.42 | 109,892 |
| 2010-01-04 | ALTH | Sale | 25,428 | 6.54 | 166,222 |
| 2010-01-05 | ALTH | Option Ex | 45,428 | 2.42 | 109,890 |
| 2009-02-04 | ALTH | Sale | 36,400 | 9.03 | 328,692 |
| 2009-02-04 | ALTH | Option Ex | 36,400 | 2.42 | 88,051 |
| 2008-09-02 | ALTH | Sale | 40,000 | 9.68 | 387,200 |
| 2008-09-02 | ALTH | Option Ex | 40,000 | 2.42 | 96,760 |
Table 4. Insider trading of Aerpio Pharmaceuticals, Inc. (ARPO) by Hoffman Stephen J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-11-12 | ARPO | Buy | 30,000 | 2.01 | 60,299 |
| 2018-11-09 | ARPO | Buy | 1,967 | 1.95 | 3,835 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Hoffman Stephen J
(Director of Aerpio Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.